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Transcriptional Regulation of Sertoli Cell Differentiation by Follicle-Stimulating Hormone
at the Level of the c-fos and Transferrin Promoters1
Jaideep Chaudhary, Patricia D. Whaley,3 Andrea Cupp, and Michael K. Skinner 2
Reproductive Endocrinology Center, University of California, San Francisco, California 94143- 0556
ABSTRACT
One of the primary endocrine hormones that influence the onset of Sertoli cell differentiation at puberty and help maintain differen-
tiation in the adult testis is FSH. FSH can modulate the majority of Sertoli cell differentiated functions, including stimulation of the iron-
binding protein transferrin. Previous studies have shown that FSH alters the levels of cAMP and the immediate early gene c-fos. The
current study was designed to investigate the transcriptional regulation of Sertoli cell differentiation by examining the actions of FSH on
the promoter of the immediate early gene c-fos and the promoter of the downstream differentiated function gene transferrin. The regulation
of c-fos by FSH was investigated with various chloramphenicol acetyltransferase (CAT) constructs containing segments of the c-fos pro-
moter, such as the serum response element (SRE), cAMP response element (CRE), and AP1/phorbol ester/TPA response element (TRE),
that were transfected into cultured Sertoli cells. Observations indicate that FSH can stimulate all three response elements, as well as a
whole c-fos promoter construct. Interestingly, FSH was found to have a more dramatic effect on the SRE-CAT than a cAMP analog,
suggesting a difference in the actions of the two agents. Gel mobility shift assays were performed to confirm the reporter gene results.
Nuclear extracts of FSH-stimulated Sertoli cells caused a labeled AP1 oligonucleotide to form a DNA/protein complex (i.e., gel shift),
indicating activation of the c-fos gene and binding of the c-fosljun complex. Nuclear extracts from both FSH- and cAMP-stimulated Sertoli
cells promoted similar gel shifts with SRE and CRE oligonucleotides. This observation supports the reporter gene data in indicating that
FSH can influence both the SRE and CRE. A gel mobility shift assay was also performed with an oligonucleotide containing the 5'-flanking
ETS domain of the SRE (ETS-SRE) that allows the formation of a ternary complex. FSH-stimulated Sertoli cell nuclear extracts were found
to promote a unique ETS-SRE gel shift not present in cAMP-stimulated cells. The observations imply that FSH actions on the SRE are in
part distinct from the actions of cAMP. Transferrin gene expression was examined to study the downstream regulation of Sertoli cell
differentiation. CAT constructs containing deletion mutants of a 3-kb mouse transferrin promoter were used. When transfected into Sertoli
cells, the 581-bp transferrin minimal promoter, previously shown to contain a CRE, had a significant response to cAMP and FSH. The 1.6-,
2.6-, and 3-kb transferrin promoter constructs also responded to FSH and cAMP to the same extent as, or to a lesser extent than, the 581-
bp minimal promoter. Interestingly, the actions of FSH on the 581-bp minimal transferrin promoter were more dramatic than those of
cAMP. The importance of FSH-induced c-fos in the regulation of transferrin expression was demonstrated in the current study when a c-
fos antisense oligonucleotide was found to partially inhibit (50%) the ability of FSH to induce the expression of a transferrin promoter
(CAT) construct. Therefore, FSH appears to act through multiple transcriptional activation pathways. The first involves cAMP and the CRE
at both early-event genes (e.g., c-fos) and downstream genes (e.g., transferrin). It is likely that other pathways involve alternate signal
transduction events (e.g., calcium mobilization) and promoter response elements (e.g., SRE). These multiple pathways may act in a
compensatory manner to assure the ability of FSH to influence Sertoli cell differentiation and/or in a synergistic manner to amplify FSH
actions.
INTRODUCTION
Within the testis, the Sertoli cell is the epithelial cell that
forms the seminiferous tubule and provides the physical
support and microenvironment required for the developing
germinal cells. Therefore, Sertoli cells have an essential role
in the control and maintenance of the process of spermat-
ogenesis. Cell fate for the Sertoli cell is determined in the
embryonic gonad at the time of testis determination. The
majority of Sertoli cell differentiated functions appear at
the onset of puberty and increase to optimal levels upon
the completion of puberty in the adult animal. The expres-
sion of a large number of specific gene products establishes
a differentiated Sertoli cell. The induction and increase in
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the expression of these genes during puberty reflect a pro-
gression of Sertoli cell differentiation. Optimal expression
of these genes in the adult reflects the maintenance of Ser-
toli cell differentiation. An example of such a Sertoli cell
gene product is the expression of the iron-binding protein
transferrin. Transferrin gene expression increases during
puberty and is maximally expressed in the adult Sertoli cell.
Therefore, the current study utilized transferrin expression
as a marker of the progression and maintenance of Sertoli
cell differentiation.
An endocrine hormone that has a specific role in influ-
encing Sertoli cell differentiation is FSH [1, 2]. Androgens
are also essential for maintaining optimal Sertoli function in
the adult. FSH acts at a G-protein-linked receptor specifi-
cally localized on Sertoli cells [3, 4]. Binding of FSH to its
receptor activates adenyl cyclase and increases the levels of
cAMP [1, 5-7]. Many of the actions of FSH on Sertoli cells
can be mimicked by cAMP [2, 81. FSH has been shown to
influence Sertoli cell gene expression through the cAMP re-
sponse element (CRE) on specific promoters [9]. Although
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cAMP is the major signal transduction pathway regulated by
FSH [1], FSH also appears to modulate other signal trans-
duction pathways. FSH has been shown to influence cal-
cium mobilization [10-12]. The cross talk of various signal
transduction pathways in Sertoli cells has been previously
investigated and established [11, 13-16]. Therefore, FSH ap-
pears to have the ability to influence Sertoli cell function
and differentiation through multiple signal transduction
pathways. FSH also appears to influence immediate-early
gene responses [17, 18]. One of the first early-event genes
found to be influenced by FSH was c-fos [19, 20]. The fos
protein is a proto-oncogene that is transiently stimulated by
a variety of mitogens and differentiation factors. FSH also
promotes a transient increase in c-fos in Sertoli cells [191.
The role c-fos has in mediating the actions of FSH on Sertoli
cell differentiated function was investigated in the current
study.
FSH influences the majority of Sertoli cell differentiated
functions previously identified [21]. A major Sertoli cell dif-
ferentiated function is synthesis of the iron-binding protein,
transferrin [22]. Transferrin is postulated to transport iron to
developing germ cells sequestered by the blood-testis bar-
rier of the seminiferous tubule [21, 22]. Transferrin expres-
sion is stimulated by FSH [8, 23, 24] and has been used as a
marker of Sertoli cell differentiation during pubertal devel-
opment [25]. The mouse and human transferrin promoters
have been partially characterized with minimal proximal
promoters that contain a CRE and other response elements
[26]. However, the hormonal regulation of the transferrin
promoter has not been previously investigated. The current
study was designed to investigate the transcriptional regu-
lation of Sertoli cell differentiation by FSH using transferrin
as a downstream gene and c-fos as an early-event gene.
MATERIALS AND METHODS
Cell Preparation and Culture
Sertoli cells were isolated from the testis of 20-day-old
rats by sequential enzymatic digestion [27] with a modified
procedure described by Tung et al. [28]. Decapsulated testis
fragments were digested first with trypsin (1.5 mg/ml;
Gibco-Bethesda Research Laboratories, Gaithersburg, MD)
to remove the interstitial cells and then with collagenase (1
mg/ml type I; Sigma Chemical Company, St. Louis, MO) and
hyaluronidase (1 mg/ml; Sigma). Sertoli cells were then
plated under serum-free conditions in 24-well Falcon plates
at 1 X 106 cells per well. Cells were maintained in a 5%
CO 2 atmosphere in Ham's F-12 medium (Gibco-BRL) with
0.1% BSA at 32°C. Sertoli cells were left untreated (control)
or were treated with either FSH (100 ng/ml; ovine [o]-FSH-
16, NHPP, Rockville, MD) or dibutyryl cAMP (dbcAMP; 0.1
mM; Sigma). These concentrations of FSH and cAMP have
previously been shown to maximally stimulate Sertoli cells.
Reporter Gene Constructs
The c-fos promoter. The chloramphenicol acetyltrans-
ferase (CAT) reporter plasmid (PBL-CAT2) with thymidine
kinase minimal promoter [29] was used to make various
c-fos promoter constructs as follows. The CRE-CAT had a
120-bp 5'-flanking sequence from the transcriptional start
site of the human c-fos promoter with 5'-TGACGTIT-3'
sequence at -60 bp. The TPA/activating protein (AP1) re-
sponse element (TRE: 5'-TGCGTCA-3')-, the serum response
element (SRE: 5'-CAGGATGTCCAAAfTAGGACATC-3')-, and
the sis-inducible element (SIE: 5'-CATTTCCCGTAAATC-3')-
CAT reporter plasmids were constructed by cloning syn-
thetic annealed oligonucleotides into PBL-CAT2 plasmid
upstream of TK minimal promoter. The entire 400-bp c-fos
promoter CAT construct was generously provided by Dr.
Jeff Holt (Vanderbilt University, Nashville, TN) [30].
Tf promoter. The CAT reporter plasmid (PUC8-CAT)
containing - 581 bp (- 581 bp mTf-CAT) and the human
growth hormone reporter plasmid containing -3.0-kb se-
quences of the mouse Tf (mTf) promoter [31] were gener-
ously provided by Dr. G. Stanley McKnight (University of
Washington, Seattle, WA). The CAT reporter plasmids con-
taining - 3.0-kb mTf promoter and its deletions were con-
structed as follows. 1) The 3.0-kb mTf-CAT construct was
made by ligating a - 3.0-kb BamHI-BamHI fragment to the
BamHI site in PGL2-CAT plasmid (Promega, Madison, WI).
2) The 2-kb upstream HindIII-HindIII fragment in the 3-kb
mTf promoter was ligated in the upstream HindIIIl site of
- 581-bp mTf-CAT to obtain the 2.6-kb mTf-CAT plasmid.
3) The -1.6-kb mTf-CAT plasmid was derived from the
-3.0-kb mTf-CAT (no. 1 above) by digesting out the up-
stream - 1.4-kb Pst I fragment.
Constructs for each of the plasmids that did not contain
the specific response element of promoter fragment (i.e.,
promoterless plasmid) were also generated. In all cases, ex-
periments were performed to examine the actions of vari-
ous treatments on these promoterless plasmids. As dis-
cussed in Results, these promoterless plasmids generally did
not respond to the treatments. If a small response was ob-
served, the data are shown in the figures or stated in Results.
Transfection
Sertoli cells cultured for 48 h were transfected with a
reporter gene construct by the calcium phosphate method
coupled with hyperosmotic shock (10% glycerol) as previ-
ously described [32]. Briefly, 1.5 fig reporter plasmid in 150
l of transfection buffer (250 mM CaC12 mixed 1:1 [v:v] with
double-strength Hepes [28 mM NaCl, 50 mM Hepes, and
1.47 mM Na2HPO4 , pH 7.05]) was added to each well of a
24-well plate containing 1 x 106 Sertoli cells in 1 ml of
Ham's F-12 with 0.1% BSA, and incubation was performed
at 32°C for 4 h. After incubation the cells were subjected to
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a hyperosmotic shock. The medium was aspirated, and 1
ml of 10% glycerol in Hanks' Balanced Salt Solution (Gibco-
BRL) was added. The cells were incubated for 3 min, and
the wells were washed twice before fresh Ham's F-12 was
added. Various treatments were subsequently added, and
cells were incubated for various time intervals before har-
vesting for CAT assays.
CATAssay
Assay of CAT activity was performed as follows. Medium
was removed from the wells, and the cells were washed
once with PBS. One hundred microliters of single-strength
cell lysis buffer (Promega) was added to each well, and
incubation was carried out for 15 min at room temperature.
The wells were then scraped and the buffer was collected
in 1.5-ml microfuge tubes. Tubes were heated to 65°C for
10 min to inactivate endogenous acetylases and then spun
at 12 000 X g for 10 min at 40C to remove cell debris. An
aliquot of cell extract (54 Il) was mixed with 65 Il1 0.25 M
Tris (pH 8.0), 25 jpg n-butyryl coenzyme A (5 mg/ml;
Sigma), and 0.1 piCi [ 4 C]-chloramphenicol (0.1 glCi/pl; ICN,
Costa Mesa, CA) and incubated overnight at 37°C. The mix-
ture was extracted once with 300 l xylene and back-ex-
tracted with 100 Il 0.25 M Tris (pH 8.0). A 200-pl aliquot of
the organic phase was counted in a scintillation counter to
determine the relative amount of CAT activity. The average
conversion of CAT substrate for treated cells ranged be-
tween 20% and 30%. This assay was found to be linear with
the protein concentration used.
Gel Mobility Shift Assay
Gel shift assays were performed with nuclear extracts of
isolated Sertoli cells. The Sertoli cells were isolated as de-
scribed above and cultured in 150 x 20-mm tissue culture
dishes (Nunclon; Nunc, Roskilde, Denmark). The cells were
treated after 48 h in culture with either FSH or dbcAMP or,
for controls, were not treated. After 72 h the cells were
scraped off the tissue culture dishes and washed once with
PBS. The nuclear extracts of these cells were then prepared
as described by Guillou et al. [33]. Typically 70-100 jig of
protein was obtained from 108 plated cells. The double-
stranded DNA probes used in gel retardation assays were
the SRE (5'-ATGTCCATATTAGGACACATCTG-3') and the
ETS-SRE element (SRE with 5'-CAGGAT sequence) of the c-
fos promoter; CRE (5'-CAGTGACGTAGGAAGTGACGTAG-
GAA-3'); AP1 dimer (5'-TCGAGTTAGTCATGAGTCAC-3');
and OCT-1 (5'-AATTCCTGATTGCATATTCATGAGAG-3').
The single-stranded oligonucleotides were 5' 32p end-la-
beled with y-32P-ATP (150 gCi/pl; New England Nuclear,
Boston, MA) and polynucleotide kinase (Boehringer-Mann-
heim, Indianapolis, IN). The complementary oligonucleo-
tides were annealed, electrophoretically purified, and then
used as probes in gel shift assays.
The gel retardation assay used was a modification of the
protocol described by Garner and Rezvin [34]. The final re-
action volume of 20 gtl contained 0.5 ng (approximately
50 000 cpm) of 5' 3 2 P-labeled double-stranded probe, 100
ng sonicated salmon sperm DNA, 2 g Poly dI-dC (U.S.
Biochemicals, Cleveland, OH), 20 jig BSA, 20 mM Hepes
(pH 8.0), 4 mM Tris (pH 7.9), 50 mM KCI, 600 jiM EDTA and
EGTA, 500 jiM dithiothreitol, and 5 g Sertoli cell nuclear
proteins. After incubation at room temperature for 20 min,
5 ll of the reaction was electrophoretically separated on a
5% polyacrylamide gel. The gel was dried and autoradio-
graphed. For the competition experiments, excess unla-
beled oligonucleotide was added in the binding reaction.
The excess oligonucleotide concentration required to ob-
tain complete displacement was found to be 100-fold molar
excess for AP1, OCT-1, CRE, and ETS-SRE, while the SRE
required 500-fold molar excess.
Antisense Procedure
A c-fos antisense oligonucleotide, 3'TACTACGGTGCA5',
was prepared and used as previously described [30, 35]. A
c-fos sense oligonucleotide was prepared for use as a neg-
ative control. Transfected Sertoli cells were treated with ei-
ther the antisense or sense oligomer (4 piM) immediately
after transfection and were re-treated every 8 h for a total
of 72 h before harvest of the cells for CAT assay.
Statistical Analysis
Each data point was converted to a percentage of the
control value, and the mean and SEM from multiple exper-
iments were determined as indicated in the figure legends.
Data were examined by ANOVA as indicated in the figure
legends.
RESULTS
To examine how FSH activates c-fos gene expression,
CAT reporter gene constructs containing different individual
regulatory elements of the c-fos promoter were generated,
including the CRE, TRE, and SRE. A schematic representa-
tion of the location of these elements within the c-fos pro-
moter is shown in Figure 1A. The sequence of the individual
elements in the constructs is presented in the Methods sec-
tion. These constructs were transiently transfected into cul-
tured Sertoli cells. After transfection, the cells were left un-
treated (control) or were treated with either FSH or dbcAMP
for 4 or 72 h. After a 4-h treatment (Fig. 1B), dbcAMP was
found to have the most dramatic effect on the CRE-CAT,
with small effects on the SRE-CAT and TRE-CAT. The whole
fos-CAT promoter was also stimulated by dbcAMP. FSH was
found to stimulate the CRE-CAT, TRE-CAT, and SRE-CAT in
a similar manner (Fig. 1B). Interestingly, FSH had a more
dramatic effect on the SRE-CAT than dbcAMP did. The effect
of FSH on the fos-CAT after 4 h was greater than effects on
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FIG. 2. Gel mobility shift assay with 32 P-radiolabeled Oct-1 and AP1 oligonucleo-
tides. Nuclear extracts from Sertoli cells cultured in the absence (C) or presence of
FSH (F) or dbcAMP (A) were used. The DNA/protein complexes were electrophor-
etically separated on 5% polyacrylamide gels and then dried and autoradiographed.
The data are representative of five different experiments.
FIG. 1. A) Schematic representation of the c-fos promoter and the location of the
CRE, SRE, and TRE in promoter-CAT constructs. The designation for the promoter
constructs is listed at the left and plasmid utilized indicated at the right. Regulation
of the c-fos promoter constructs (CRE, TRE, and SRE) in Sertoli cells cultured in the
absence (control) or presence of FSH and dbcAMP for 4 h (B) and 72 h (C). Data are
expressed as percentage of control and presented as the mean SEM from six
different experiments done in replicate. The statistical analysis (ANOVA) is shown,
with different letters indicating a statistical difference (p < 0.001) within each CAT
construct group individually.
the individual elements. After a 72-h treatment (Fig. 1C),
dbcAMP was found to stimulate CRE-CAT, TRE-CAT, SRE-
CAT, and fos-CAT to the same extent. FSH stimulated CRE-
CAT, TRE-CAT, andfos-CAT in a manner similar to dbcAMP.
Interestingly, FSH had a more dramatic effect on the SRE-
CAT, and this response was twice the response seen with
dbcAMP (Fig. 1C). Promoterless control plasmids were not
significantly affected by dbcAMP or FSH treatments (data
not shown). The CAT activity under control conditions was
found to be similar for SRE, CRE, and c-fos, while the TRE
had a 2-3-fold higher basal level of activity. It is likely that
the basal TRE level was higher because the TRE is respon-
sive to the protein kinase C pathway and also has an AP-1
motif to which fos/jun can bind and activate fos expression.
As expected, the activity at 72 h was significantly higher
than at 4 h. Therefore, FSH can act at response elements
other than the CRE, in particular the SRE, to regulate c-fos
promoter activation.
To extend these observations, gel retardation/mobility
shift assays were performed. Nuclear extracts were obtained
from Sertoli cells cultured in the absence (control; C) or
presence of FSH or dbcAMP. A gel shift with an oligonucle-
otide to Oct-i was used to check the quality of the nuclear
extract (Fig. 2). All the extracts resulted in a similar amount
of Oct-i gel shift. To confirm that c-fos was induced, a gel
shift with an AP1 oligonucleotide was performed, since the
c-fos/jun complex binds to the AP1 site. Incubation of the
labeled AP1-DNA fragment with nuclear extracts of Sertoli
cells treated with FSH or dbcAMP resulted in the formation
of a DNA/protein complex (i.e., gel shift). The observed gel
shift was specific for AP1 since it could be effectively inhib-
ited by unlabeled AP1 (Fig. 2). The optimum concentration
for unlabeled oligonucleotide competition experiments is
specified in Materials and Methods. The presence of c-
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FIG. 3. Gel mobility shift assay with 32P-radiolabeled SRE, ETS-SRE, and CRE oli-
gonucleotides. Nuclear extracts from Sertoli cells cultured in the absence (C) or
presence of FSH (F) or dbcAMP (A) were used. The DNA/protein complexes were
electrophoretically separated on 5% polyacrylamide gels and then dried and auto-
radiographed. The data represent a minimum of three different experiments.
fos in this AP1 gel shift was confirmed with an immunoblot
of the gel shift with a c-fos antibody (data not shown). This
confirmed the induction of c-fos by both FSH and cAMP.
The activation of the SRE of the c-fos promoter was also
investigated with a gel mobility shift assay using an SRE
oligonucleotide (Fig. 3). FSH and dbcAMP induced a gel
shift that was inhibited with excess unlabeled SRE. To de-
termine whether a ternary complex could be induced, an
SRE-ETS oligonucleotide gel shift was done. The ETS do-
main, previously shown to bind Ets oncogenes, is a
5'-CAGGAT sequence to the SRE and is required to obtain
a ternary complex with the serum response factor (SRF)
binding to the SRE. FSH promoted an SRE-ETS gel shift that
was distinct from that of dbcAMP (Fig. 3). Therefore, FSH
promotes the formation of an apparent ternary complex
with an SRE-ETS sequence that is distinct from dbcAMP ac-
tions (Fig. 3). FSH and cAMP were also found to induce a
gel shift with a CRE oligonucleotide (Fig. 3) that was inhib-
ited with excess unlabeled CRE (data not shown). There-
fore, FSH induced protein binding to the SRE and CRE oli-
gonucleotides. The results correlate with the reporter gene
data outlined above and suggest that FSH may act through
both the SRE and CRE to promote c-fos gene expression.
In order to determine the location of response elements
within the transferrin promoter that are activated by treat-
ment with FSH, four CAT constructs containing either a 581-
bp, 1.6-kb, 2.6-kb, or 3-kb upstream region of the mouse
transferrin promoter were used (Fig. 4A). The minimal 581-
bp promoter was previously shown to contain a CRE [26].
Cyclic AMP was found to stimulate all the transferrin pro-
moter constructs in a similar manner (Fig. 4B). FSH had the
most dramatic effect on the minimal 581-bp promoter, and
this level was nearly twice that obtained with dbcAMP. FSH
FIG. 4. A) Schematic representation of the transferrin promoter-CAT constructs.
B) Regulation of the various transferrin promoter-CAT constructs in Sertoli cells
cultured in the absence (Control) or presence of FSH or dbcAMP. Data are expressed
as percentage of control (nontreated) cells and presented as the mean ± SEM from
five different experiments done in replicate. The statistical analysis (ANOVA) is
shown with different letters indicating a statistical difference (p< 0.001) within each
CAT construct group individually.
actions on the 1.6-, 2.6-, and 3-kb promoter constructs were
the same as those found with cAMP. Therefore, the minimal
581-bp promoter appears to contain the required elements
for cAMP and FSH to activate transferrin gene expression.
The basal CAT activity under control conditions for all the
constructs was found to be similar. A promoter construct
that had the 581-bp minimal promoter deleted and con-
tained only a 1-kb promoter fragment between - 1.6 kb and
- 2.6 kb was found not to be activated by either FSH or
dbcAMP treatment (data not shown). FSH appears to pri-
marily utilize the 581-bp minimal promoter to activate trans-
ferrin expression and has a more dramatic effect than cAMP
alone.
To confirm that c-fos is involved at a molecular level in
FSH stimulation of transferrin, a CAT reporter gene con-
struct containing - 2.6 kb of the transferrin gene promoter
was transiently transfected into cultured Sertoli cells. After
transfection, the cells were left untreated (control) or were
treated with FSH, a combination of FSH and the antisense
c-fos oligonucleotide, or a combination of FSH and the
sense c-fos oligonucleotide for 72 h before analysis of the
cell extracts for CAT activity. FSH and the combination of
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FSH and the sense oligonucleotide activated the transferrin
CAT construct (Fig. 5). The c-fos antisense oligonucleotide
partially inhibited (approximately 50% inhibition) the ac-
tions of FSH (Fig. 5). Therefore, c-fos appears to be partially
involved in the ability of FSH to activate the transferrin pro-
moter, but other more direct cis-acting elements (e.g., CRE)
will also be involved.
DISCUSSION
FSH is known to have the ability to influence Sertoli cell
differentiation through a classical cAMP-dependent signal
transduction pathway [1]. However, FSH can also influence
other signal transduction pathways (e.g., calcium mobili-
zation) that can alter Sertoli cell function [1, 10-16]. The
current study investigated the ability of FSH to influence
the transcriptional regulation of Sertoli cell differentiation.
The possibility that FSH may also influence multiple tran-
scriptional events was considered using both an immediate-
early response gene and a downstream gene. FSH is known
to alter early-event genes [17], in particular, c-fos [18-20].
FSH causes a transient increase in c-fos mRNA in Sertoli cells
[19]. A downstream differentiated function of Sertoli cells is
transferrin gene expression that has also been shown to be
stimulated by FSH [8, 23, 24]. The actions of FSH on the
promoters of c-fos and transferrin were examined to provide
insight into the transcriptional regulation of Sertoli differ-
entiation.
Analysis of the actions of FSH on various individual re-
sponse elements of the c-fos promoter indicated that the
CRE-CAT, TRE-CAT, and SRE-CAT can all be activated as
well as the whole c-fos promoter. The CRE was activated to
the same extent by FSH and cAMP. This confirms previous
observations on the ability of a CRE to mediate the actions
of FSH on Sertoli cell genes [8, 9]. FSH and dbcAMP also
promoted a gel shift with a CRE oligonucleotide. CRE-bind-
ing proteins have been postulated previously to be involved
in the actions of FSH [36]. The CRE on some promoters have
been shown to bind the CRE-binding protein (CREB).
Whether the CREB or other proteins participate in the CRE
gel shift shown in the current study remains to be eluci-
dated. Therefore, as expected, the CRE of the c-fos promoter
may have an important role in activation of c-fos expression.
In addition to the CRE, the TPA response element TRE was
also activated by FSH. The response to FSH at 4 h was
greater than that to cAMP but was similar at 72 h. The TRE
utilized was located at - 290 bp of the c-fos promoter and
is also known to contain an AP1 site [37]. Therefore, this
element can respond to an autoregulatory c-fos expression.
Results imply that FSH can influence this TRE element to
influence c-fos expression. Whether this activation entails a
calcium mobilization and/or protein kinase C activation vs.
an autoregulation involving c-fos/jun remains to be eluci-
dated.
FIG. 5. Regulation of the 2.6-kb transferrin promoter-CAT construct (Tf-CAT) in
Sertoli cells cultured in the absence (Control) or presence of FSH FSH), FSH and c-
fos antisense oligonucleotide (FSH +Anti), or FSH and c-fos sense oligonucleotide
(FSH +Sense). The effect of FSH on the promoterless plasmid (pUC-8 CAT) is indi-
cated. Data are expressed as percentage of control and as ANOVA results with
different letters indicating a statistical difference (p < 0.001) between treatments.
Data are presented as the mean + SEM from three different experiments done in
replicate.
The SRE was also activated by FSH and was the most
active promoter at 72 h. This increased activity may have
been due to a differentiation response at 72 h, whereas it is
likely that at 4 h the activation was exclusively an immediate
signal transduction response. FSH had a more dramatic ef-
fect than cAMP at both 4- and 72-h treatments. FSH also
promoted a gel shift with an SRE oligonucleotide. This ob-
servation supports the reporter gene results and demon-
strates the ability of FSH to promote the presence of tran-
scriptional regulators that bind the SRE. SRE is a 29-bp
region within the c-fos promoter. The 14-bp inner core con-
tains the sequence [CC(A/T) 6GG], which is referred to as the
CArG box. Transcriptional regulators bind to this sequence,
and their binding is stabilized by the two outer arms of the
element, which are palindromic [38]. A 67-kDa protein has
been isolated that binds to the SRE-the serum response
factor (SRF) [39]. SRF is a highly conserved, dimeric protein
with novel DNA-binding structure. The DNA-binding do-
main of SRF, amino acids 93-222, is also the region nec-
essary for dimerization and interaction with other proteins
to form ternary complexes [39]. Because SRF is ubiquitously
expressed, cell-specific activation of the c-fos SRE by SRF
appears to be mediated by these other protein factors. The
binding of the ternary complex to the SRE requires the pres-
ence of adjoining 5'-flanking sequence of the SRE-binding
site, the ETS domain-binding motif. The protein kinase C-
dependent and -independent pathways target different
parts of this SRE-ETS ternary complex [40]. One protein re-
quired for serum-induced activation of the SRE by SRF is
the 62-kDa, p62 ternary complex factor (p62TCF). Gel shift
data demonstrated a 50-fold increase in the affinity of SRE
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for the SRF/p62 TCF complex over that for SRF alone [39].
Another protein that binds SRF is elk-1 protein, which may
be structurally related to p62TCF [41, 42]. The elk-1 protein is
phosphorylated through the activation of MAP kinase path-
way by growth factors. The TCF formed between phospho-
rylated elk-1 and SRF results in a readily distinguishable
DNA-protein complex as compared to SRF alone [43]. The
identity of the FSH-induced SRE-binding protein as SRF or
other binding proteins remains to be elucidated. FSH also
induced a unique gel shift with the SRE-ETS that was not
observed in control nontreated cells or in cAMP analog-
treated cells. Therefore, FSH appears to promote the for-
mation of a protein complex (i.e., ternary complex) distinct
from cAMP that activates the SRE within the c-fos promoter.
The formation of these ternary complexes may enable a
common regulatory element, such as the SRE, to have cell-
specific activity using ubiquitously expressed DNA-binding
protein. Alternatively, different or unique binding factors
may be another method by which a common regulatory el-
ement may differentially activate cell-specific gene expres-
sion.
Combined observations indicate that FSH can activate c-
fos expression through multiple response elements (e.g.,
CRE and SRE). Previously, multiple sequence elements in
the c-fos promoter have been shown to be induced by cAMP
[44]. In addition, the SRE was found not to mediate cAMP
induction of c-fos [45]. These observations support the cur-
rent results indicating that FSH appears to act at multiple
response elements and transcriptional activation pathways.
The sequences of the c-fos response elements used are pre-
sented above; no known response elements are present
within these sequences other than those listed. The possible
presence of unknown response elements cannot be ruled
out. Mutagenesis experiments with these elements are
needed to unequivocally identify a specific element as me-
diating FSH actions. However, observations do indicate that
multiple elements appear to mediate FSH actions, and this
correlates with the ability of FSH to influence multiple signal
transduction pathways.
The downstream effects of FSH were investigated using
the transferrin gene as a differentiated marker of Sertoli
cells. The regions controlling liver-specific transcription of
the human transferrin gene are composed of multiple pos-
itive- and negative-acting elements, mostly interacting with
DNA-binding proteins present in either human or rat liver
nuclear extracts [46, 47]. The regulation of the transferrin
gene expression in unstimulated Sertoli cells has been
shown to be distinct from that for liver gene expression [48].
Although the first 581 bp of human transferrin promoter
(hTf) and mouse transferrin promoter (mTf) have little sim-
ilarity, they both contain a CRE site that was found in the
current study to be responsive to FSH. The results for the
CAT-mTF deletion mutants suggest that the enhancer activ-
ity for FSH and cAMP is located in the 581-bp minimal pro-
moter. The upstream 2.5 kb of promoter was found to
provide equivalent or decreased activity. Therefore, the
581-bp minimal promoter appears to be sufficient for FSH-
regulated transferrin expression. One mechanism FSH can
use to regulate transferrin expression is through the CRE
located in the minimal promoter. What function c-fos ex-
pression may have in mediating FSH actions was investi-
gated with an antisense c-fos oligonucleotide. The antisense
c-fos was found to partially (50%) inhibit FSH-induced ac-
tivation of the transferrin promoter in Sertoli cells. The an-
tisense c-fos procedure does have the capacity to com-
pletely inhibit c-fos actions as shown with another Sertoli
cell regulator (i.e., PModS) [49] (data not shown). The ability
of the antisense c-fos to partially inhibit FSH actions sug-
gests that c-fos in part mediates FSH activation of the trans-
ferrin promoter. Therefore, in addition to actions on the
CRE, FSH also appears to utilize the early-event gene c-fos.
The CRE as well as the c-fos response appears to be an
early-event response to FSH and not a secondary indirect
response to one or the other. FSH appears to regulate mul-
tiple transcriptional activation pathways to modulate Sertoli
cell differentiation.
In considering the transcriptional regulation of Sertoli
cell differentiation, the ability of FSH to influence multiple
signal transduction and transcriptional activation pathways
is an issue to address. These multiple pathways may act in
a compensatory manner to assure the activation of Sertoli
cell differentiation by FSH. This may have evolved because
of the importance of Sertoli cell differentiation and sper-
matogenesis to male reproduction. Alternatively, these
transduction pathways may act synergistically to amplify
FSH actions on Sertoli differentiation. In support of this, the
581-bp transferrin minimal promoter was activated to a
greater extent by FSH than by cAMP. In addition, the c-fos
antisense experiment only partially inhibited FSH actions.
This suggests that possible synergistic actions of multiple
transcriptional activation pathways are possible.
The ability of FSH to activate multiple transduction path-
ways implies that FSH may be a general activator of the
Sertoli cell. This may be essential in the progression and
maintenance of Sertoli differentiation. Other regulatory
agents with more specific transduction pathways may be
needed for the initial induction of Sertoli cell differentiation.
The actions of FSH may also be needed to make the Sertoli
cell responsive to other regulatory agents. Further analysis
of the transcriptional regulation of Sertoli cell differentiation
will involve the identification of important transcription fac-
tors and cis-acting elements in a variety of Sertoli cell dif-
ferentiated genes.
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